Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

5-azacytidine induces anoikis, inhibits mammosphere formation and reduces metalloproteinase 9 activity in MCF-7 human breast cancer cells.

Chang HW, Wang HC, Chen CY, Hung TW, Hou MF, Yuan SS, Huang CJ, Tseng CN.

Molecules. 2014 Mar 13;19(3):3149-59. doi: 10.3390/molecules19033149.

2.

Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells.

Fiucci G, Ravid D, Reich R, Liscovitch M.

Oncogene. 2002 Apr 4;21(15):2365-75.

3.

Brefeldin A reduces anchorage-independent survival, cancer stem cell potential and migration of MDA-MB-231 human breast cancer cells.

Tseng CN, Hong YR, Chang HW, Yu TJ, Hung TW, Hou MF, Yuan SS, Cho CL, Liu CT, Chiu CC, Huang CJ.

Molecules. 2014 Oct 29;19(11):17464-77. doi: 10.3390/molecules191117464.

4.

Sublethal concentrations of the platinum(II) complex [Pt(O,O'-acac)(gamma-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells.

Muscella A, Calabriso N, Vetrugno C, Urso L, Fanizzi FP, De Pascali SA, Marsigliante S.

Br J Pharmacol. 2010 Jul;160(6):1362-77. doi: 10.1111/j.1476-5381.2010.00782.x.

5.

The combination of sorafenib and radiation preferentially inhibits breast cancer stem cells by suppressing HIF-1α expression.

Lee JH, Shim JW, Choi YJ, Heo K, Yang K.

Oncol Rep. 2013 Mar;29(3):917-24. doi: 10.3892/or.2013.2228. Epub 2013 Jan 8.

6.

Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.

Tang FY, Chiang EP, Sun YC.

J Nutr Biochem. 2008 May;19(5):287-94. Epub 2007 Jul 24.

PMID:
17651959
7.

The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest.

Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY.

Phytomedicine. 2010 May;17(6):436-40. doi: 10.1016/j.phymed.2009.08.012. Epub 2009 Oct 2.

PMID:
19800775
8.

Brefeldin a effectively inhibits cancer stem cell-like properties and MMP-9 activity in human colorectal cancer Colo 205 cells.

Tseng CN, Huang CF, Cho CL, Chang HW, Huang CW, Chiu CC, Chang YF.

Molecules. 2013 Aug 22;18(9):10242-53. doi: 10.3390/molecules180910242.

9.
10.
11.

The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.

Fang XJ, Jiang H, Zhao XP, Jiang WM.

BMC Cancer. 2011 Jul 12;11:290. doi: 10.1186/1471-2407-11-290.

12.

Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.

Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY.

Carcinogenesis. 2009 Jul;30(7):1225-33. doi: 10.1093/carcin/bgp111. Epub 2009 May 6.

PMID:
19420016
13.

Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.

Hurtubise A, Momparler RL.

Cancer Chemother Pharmacol. 2006 Nov;58(5):618-25. Epub 2006 Jun 17.

PMID:
16783580
15.

Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells.

Wołczynski S, Surazyński A, Swiatecka J, Pałka J.

Gynecol Endocrinol. 2001 Jun;15(3):225-33.

PMID:
11447735
16.

The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system.

Wiercinska E, Naber HP, Pardali E, van der Pluijm G, van Dam H, ten Dijke P.

Breast Cancer Res Treat. 2011 Aug;128(3):657-66. doi: 10.1007/s10549-010-1147-x. Epub 2010 Sep 5.

PMID:
20821046
17.

The bacterial protein azurin impairs invasion and FAK/Src signaling in P-cadherin-overexpressing breast cancer cell models.

Bernardes N, Ribeiro AS, Abreu S, Mota B, Matos RG, Arraiano CM, Seruca R, Paredes J, Fialho AM.

PLoS One. 2013 Jul 19;8(7):e69023. doi: 10.1371/journal.pone.0069023. Print 2013.

18.

RABEX-5 plays an oncogenic role in breast cancer by activating MMP-9 pathway.

Zhang X, Min J, Wang Y, Li Y, Li H, Liu Q, Liang X, Mu P, Li H.

J Exp Clin Cancer Res. 2013 Aug 13;32(1):52. doi: 10.1186/1756-9966-32-52.

19.

TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells.

Brunquell C, Biliran H, Jennings S, Ireland SK, Chen R, Ruoslahti E.

Mol Cancer Res. 2012 Nov;10(11):1482-95. doi: 10.1158/1541-7786.MCR-12-0144. Epub 2012 Sep 4.

20.

(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.

Farabegoli F, Papi A, Orlandi M.

Biosci Rep. 2011 Apr;31(2):99-108. doi: 10.1042/BSR20090143.

PMID:
20446926

Supplemental Content

Support Center